LATEST

• BUSINESS Daiichi Sankyo Cuts FY2027 Net Profit Outlook on Higher Tax Burden
  August 3, 2026

• BUSINESS Kissei Slashes Tavneos Sales Forecast after Safety, Data Concerns
  August 3, 2026

• REGULATORY Unami Tapped as Japan’s New Top Finance Bureaucrat
  August 3, 2026

• BUSINESS Forxiga Exit Weighs on Ono’s Japan Sales, but Boosts Profit
  August 3, 2026

• BUSINESS Bayer, JFCR Ink Strategic Oncology R&D Partnership
  August 3, 2026

• BUSINESS CSL Debuts Higher-Dose Hizentra Prefilled Syringe in Japan
  August 3, 2026

• REGULATORY MHLW Names Uchiyama New Pharma Bureau Chief in Senior Shakeup
  August 3, 2026

• ORGANIZATION New Chuikyo Pharmacist Rep Urges 2027 Revision to Stay within 4-Minister Deal
  August 3, 2026

• BUSINESS Taisho Bags Japan Rights to Kaigene’s FcRn Inhibitor KG006
  August 3, 2026

• BUSINESS Datroway Lands EU Approval in 1st-Line TNBC
  August 3, 2026

• BUSINESS Chugai Files Enspryng for MOGAD Relapse Prevention in Japan
  August 3, 2026

• BUSINESS Takeda CEO Says Orzeyful Could Redefine NT1 Standard of Care
  July 31, 2026

• BUSINESS Pfizer Seeks Pediatric Expansion for Hympavzi in Japan
  July 31, 2026

• BUSINESS Nippon Shinyaku Exercises Option for AB2 Bio’s Tadekinig Alfa in US
  July 31, 2026

• ORGANIZATION Ectopic Fat Research Group Launches to Push Cross-Disciplinary Studies
  July 31, 2026

• BUSINESS Alfresa Takes Stake in Ember to Bolster Pharma Cold Chain in Japan
  July 31, 2026

• ORGANIZATION JPMA Chief Seeks Concrete Reforms to Reward Innovation after Honebuto
  July 31, 2026

• ORGANIZATION Patient Groups Launch Consortium to Improve Access to Drug Information
  July 31, 2026

• BUSINESS Sanwa Kagaku Says Kumamoto Plant Remains Shut, Drug Supplies Stable
  July 31, 2026

• REGULATORY Japan to Ease Olanzapine Diabetes Contraindication for Antiemetic Use
  July 31, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• …
• Next ›
• 最終 »